APA (7th ed.) Citation

Kurniawan, H., Nickels, S. L., Zagare, A., Zuccoli, E., Rosety, I., Gomez-Giro, G., . . . Schwamborn, J. C. (2025). The Parkinson's disease-associated LRRK2-G2019S variant restricts serine metabolism, leading to microglial inflammation and dopaminergic neuron degeneration. Journal of Neuroinflammation, 22(1), 1. https://doi.org/10.1186/s12974-025-03577-2

Chicago Style (17th ed.) Citation

Kurniawan, Henry, Sarah L. Nickels, Alise Zagare, Elisa Zuccoli, Isabel Rosety, Gemma Gomez-Giro, Enrico Glaab, and Jens C. Schwamborn. "The Parkinson's Disease-associated LRRK2-G2019S Variant Restricts Serine Metabolism, Leading to Microglial Inflammation and Dopaminergic Neuron Degeneration." Journal of Neuroinflammation 22, no. 1 (2025): 1. https://doi.org/10.1186/s12974-025-03577-2.

MLA (9th ed.) Citation

Kurniawan, Henry, et al. "The Parkinson's Disease-associated LRRK2-G2019S Variant Restricts Serine Metabolism, Leading to Microglial Inflammation and Dopaminergic Neuron Degeneration." Journal of Neuroinflammation, vol. 22, no. 1, 2025, p. 1, https://doi.org/10.1186/s12974-025-03577-2.